NCT05016310 2025-07-23
A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation
Wake Forest University Health Sciences
Phase NA Completed
Clinical Trials
18 trialsNCT03629717 2024-10-16
RANKL Inhibition and Breast Tissue Biomarkers
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT01224678 2024-10-08
Vitamin D and Breast Cancer Biomarkers in Female Patients
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00365105 2024-09-20
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT02186015 2021-05-14
SAFE-D
Loyola University
Phase 2 Completed
NCT04166253 2021-02-03
VDDOXO
Damanhour University
Phase 2 Completed
NCT04091178 2019-09-16
OPTIVIT
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Completed
NCT00867217 2018-02-09
VITAL
University of Kansas Medical Center
Phase 2 Completed
NCT00656019 2017-12-02
Development of Vitamin D as a Therapy for Breast Cancer - Phase 2
Stanford University
Phase 2 Completed
NCT01425476 2017-08-09
Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors
Hartford Hospital
Phase 1/2 Completed
NCT01965522 2017-06-16
MELO-D
Juravinski Cancer Center
Phase 2 Completed
NCT00022087 2016-07-19
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00054418 2016-07-13
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00073073 2016-05-17
Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
Georgetown University
Phase 2 Completed
NCT00000611 2016-04-15
Women's Health Initiative (WHI)
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3 Completed
NCT01948128 2016-02-03
OTT 12-06
Ottawa Hospital Research Institute
Phase 2 Completed
NCT00263185 2014-09-22
High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT01240213 2013-08-07
ViDA
Fred Hutchinson Cancer Center
Phase NA Completed